|
MTERF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.438960E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.447200E-01 |
| Normal-vs-Stage2 |
2.553800E-01 |
| Normal-vs-Stage3 |
4.664800E-01 |
| Normal-vs-Stage4 |
6.391200E-01 |
| Stage1-vs-Stage2 |
2.628200E-01 |
| Stage1-vs-Stage3 |
4.174600E-01 |
| Stage1-vs-Stage4 |
6.878600E-01 |
| Stage2-vs-Stage3 |
2.157000E-01 |
| Stage2-vs-Stage4 |
3.194600E-01 |
| Stage3-vs-Stage4 |
4.115000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.769400E-01 |
| Normal-vs-AfricanAmerican |
2.450200E-01 |
| Normal-vs-Asian |
1.878330E-02 |
| Caucasian-vs-AfricanAmerican |
3.165000E-01 |
| Caucasian-vs-Asian |
3.894500E-02 |
| AfricanAmerican-vs-Asian |
3.816000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.959570E-01 |
| Normal-vs-Female |
3.426400E-01 |
| Male-vs-Female |
5.553800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.011200E-01 |
| Normal-vs-Extreme_Weight |
9.856200E-01 |
| Normal-vs-Obese |
2.856400E-01 |
| Normal-vs-Extreme_Obese |
8.013200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.406600E-01 |
| Normal_Weight-vs-Obese |
2.044400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.696000E-01 |
| Extreme_Weight-vs-Obese |
2.974600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.005200E-01 |
| Obese-vs-Extreme_Obese |
4.884200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.364600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.028400E-02 |
| Normal-vs-Age(61-80Yrs) |
4.452800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.677390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.764400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.656800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.697800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.818800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.745600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.024780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.830370E-02 |
| Normal-VS-Type2 PRCC |
1.039950E-02 |
| Normal-VS-KIRP CIMP |
5.365000E-01 |
| Normal-VS-Unclassified PRCC |
4.836800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.805780E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.652500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.365600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.867000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.749700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.449000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.345200E-01 |
| Normal-vs-N1 |
1.746830E-01 |
| Normal-vs-N2 |
1.77727999999266E-05 |
| N0-vs-N1 |
4.175900E-02 |
| N0-vs-N2 |
4.363800E-02 |
| N1-vs-N2 |
1.389670E-02 |
|
|
